Editorial: Choosing New Targets for Rheumatoid Arthritis Therapeutics: Too Interesting to Fail? (2017)
Attributed to:
Glasgow Molecular Pathology (GMP) Node
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/art.40082
PubMed Identifier: 28245351
Publication URI: http://europepmc.org/abstract/MED/28245351
Type: Journal Article/Review
Volume: 69
Parent Publication: Arthritis & rheumatology (Hoboken, N.J.)
Issue: 6
ISSN: 2326-5191